Skip to content

A Study on Intestinal Microecology in Patients with Chronic Constipation Treated by Sacral Nerve Magnetic Stimulation Combined with Transcutaneous Auricular Vagus Nerve Stimulation

A Study on Intestinal Microecology in Patients with Chronic Constipation Treated by Sacral Nerve Magnetic Stimulation Combined with Transcutaneous Auricular Vagus Nerve Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122424
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic constipation

Interventions

control group:sacral magnetic stimulation+transcutaneous auricular sham stimulation
experimental group:transcutaneous auricular vagus nerve stimulation+sacral magnetic stimulation

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–80 years old; 2. Meet the Rome IV criteria and the "Chinese Clinical Guidelines for the Diagnosis and Treatment of Chronic Constipation": bowel movements less than 3 times per week, difficulty in defecation, straining, small stool volume, may be accompanied or not by abdominal pain, bloating, anorectal pain, and other discomforts; 3. Willing to sign a written informed consent, compliant, and able to cooperate with treatment.

Exclusion criteria

Exclusion criteria: 1. Combined severe cardiovascular, respiratory system diseases, diabetes, kidney disease, and chronic diseases related to gastrointestinal problems; 2. Implanted electronic devices (e.g., pacemakers) or metal devices (e.g., metal IUDs); 3. Combined psychiatric disorders; 4. Women who are pregnant or planning pregnancy; 5. Abdominal surgery within the past 6 months; 6. Allergic reactions to surface electrodes; 7. Use of probiotics or antibiotics within 2 weeks before enrollment (to minimize effects on gut microbiota)..

Design outcomes

Primary

MeasureTime frame
Characteristics of gut microbiota;Anorectal manometry;patient assessment constipation quality life ,PAC-QOL;Constipation Symptom Score;Autonomic nerve function assessment;

Countries

China

Contacts

Public ContactYe Jing

Beijing Haidian Hospital

19611681@qq.com+86 10 8269 3306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026